For endocrinologists, accurate prediction of obesity severity (e.g., BMI classification, visceral adiposity grading) is pivotal for early risk stratification of hormone-dependent comorbidities and for designing personalized interventions (e.g., lifestyle guidance, insulin sensitizers) (3). The gene discussed is INS; the disease is obesity disorder.